|
1
|
Dotto GP and Rustgi AK: Squamous cell cancers: A unified perspective on biology and genetics. Cancer Cell. 29:622–637. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chi AC, Day TA and Neville BW: Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Silverman S Jr: Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 132 (Suppl):S7–S11. 2001. View Article : Google Scholar
|
|
5
|
Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F and Soerjomataram I: The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 67:51–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Gu J, Xu F, Zhu Q, Ge D and Lu C: Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data. Sci Rep. 8:158342018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma B and Kanwar SS: Phosphatidylserine: A cancer cell targeting biomarker. Semin Cancer Biol. 52:17–25. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loong HH, Kwan SS, Mok TS and Lau YM: Therapeutic strategies in EGFR mutant non-small cell lung cancer. Curr Treat Options Oncol. 19:582018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New Engl J Med. 354:567–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, et al: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, et al: Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): An open-label, randomised, controlled phase 3 trial. Lancet Oncol. 16:763–774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nielsen HL, Ronnov-Jessen L, Villadsen R and Petersen OW: Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics. 79:703–710. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tran-Thanh D and Done SJ: The role of stromal factors in breast tumorigenicity. Am J Pathol. 176:1072–1074. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Neergaard M, Kim J, Villadsen R, Fridriksdottir AJ, Rank F, Timmermans-Wielenga V, Langerød A, Børresen-Dale AL and Petersen OW: Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am J Pathol. 176:1229–1240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim YH, Lee JR and Hahn MJ: Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1). Biochem Biophys Res Commun. 496:778–783. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SC, Hong CW, Jang SG, Kim YA, Yoo BC, Shin YK, Jeong SY, Ku JL and Park JG: Establishment and characterization of paired primary and peritoneal seeding human colorectal cancer cell lines: Identification of genes that mediate metastatic potential. Transl Oncol. 11:1232–1243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hastie E, Cataldi M, Moerdyk-Schauwecker MJ, Felt SA, Steuerwald N and Grdzelishvili VZ: Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Oncotarget. 7:61601–61618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li T, Lu H, Shen C, Lahiri SK, Wason MS, Mukherjee D, Yu L and Zhao J: Identification of epithelial stromal interaction 1 as a novel effector downstream of Kruppel-like factor 8 in breast cancer invasion and metastasis. Oncogene. 33:4746–4755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Capdevila-Busquets E, Badiola N, Arroyo R, Alcalde V, Soler-Lopez M and Aloy P: Breast cancer genes PSMC3IP and EPSTI1 play a role in apoptosis regulation. PLoS One. 10:e01153522015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fijak M and Meinhardt A: The testis in immune privilege. Immunol Rev. 213:66–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kosova G, Scott NM, Niederberger C, Prins GS and Ober C: Genome-wide association study identifies candidate genes for male fertility traits in humans. Am J Human Genet. 90:950–961. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ishii T, Onda H, Tanigawa A, Ohshima S, Fujiwara H, Mima T, Katada Y, Deguchi H, Suemura M, Miyake T, et al: Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res. 12:429–439. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun JL, Zhang HZ, Liu SY, Lian CF, Chen ZL, Shao TH, Zhang S, Zhao LL, He CM, Wang M, et al: Elevated EPSTI1 promote B cell hyperactivation through NF-kappaB signalling in patients with primary Sjogren's syndrome. Ann Rheum Dis. 79:518–524. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng X, Yang D, Yu R and Zhu H: EPSTI1 is involved in IL-28A-mediated inhibition of HCV infection. Mediators Inflamm. 2015:7163152015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H and Tanzawa H: Hyaluronan-mediated motility: A target in oral squamous cell carcinoma. Int J Oncol. 32:1001–1009. 2008.PubMed/NCBI
|
|
26
|
Peng CH, Liao CT, Peng SC, Chen YJ, Cheng AJ, Juang JL, Tsai CY, Chen TC, Chuang YJ, Tang CY, et al: A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One. 6:e234522011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, et al: Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Douglas NC and Papaioannou VE: The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 18:143–147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du WL, Fang Q, Chen Y, Teng JW, Xiao YS, Xie P, Jin B and Wang JQ: Effect of silencing the TBox transcription factor TBX2 in prostate cancer PC3 and LNCaP cells. Mol Med Rep. 16:6050–6058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khalil AA, Sivakumar S, Lucas FAS, McDowell T, Lang W, Tabata K, Fujimoto J, Yatabe Y, Spira A, Scheet P, et al: TBX2 subfamily suppression in lung cancer pathogenesis: A high-potential marker for early detection. Oncotarget. 8:68230–68241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, et al: Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas. Oncotarget. 10:1306–1319. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ding M, He SJ and Yang J: MCP-1/CCL2 mediated by autocrine loop of PDGF-BB promotes invasion of lung cancer cell by recruitment of macrophages via CCL2-CCR2 axis. J Interferon Cytokine Res. 39:224–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
De la Fuente Lopez M, Landskron G, Parada D, Dubois-Camacho K, Simian D, Martinez M, Romero D, Roa JC, Chahuán I, Gutiérrez R, et al: The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer. Tumour Biol. 40:10104283188100592018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, Sugano G, Kato Y, Li J and Pollard JW: CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 212:1043–1059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ling Z, Yang X, Chen X, Xia J, Cheng B and Tao X: CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma. J Oral Pathol Med. 48:477–482. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu Y, Liu WB, Liu KJ, Ao L, Cao J, Zhong JL and Liu JY: Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields. Cell Cycle. 15:357–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee JY, Tokumoto M, Hwang GW, Lee MY and Satoh M: Identification of ARNT-regulated BIRC3 as the target factor in cadmium renal toxicity. Sci Rep. 7:172872017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Watanabe J, Takiyama Y, Honjyo J, Makino Y, Fujita Y, Tateno M and Haneda M: Role of IGFBP7 in diabetic nephropathy: TGF-β1 induces IGFBP7 via Smad2/4 in human renal proximal tubular epithelial cells. PLoS One. 11:e01508972016. View Article : Google Scholar : PubMed/NCBI
|
